Advertisement
Advertisement
PTCT
PTC Therapeutics Inc
46.20
USD+0.95
+2.10%
Dec 20, 15:59 UTC -5
Closed
...
PTC Therapeutics Inc Profile
About
Info & Links
CEO
Mathew B. Klein
Headquarters
SOUTH PLAINFIELD, NJ 07080, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
98
Employees
995
PTC Therapeutics Inc Statistics
Valuation Measures
Market Capitalization2
3.56B
Enterprise Value
5.42B
Enterprise Value/EBITDA(ttm)
1.24K
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
3.87
Price to Book(mrq)
--
Price to Cash(ytd)
18.68
Profitability
Gross Margin(ttm)
92.42%
Operating Margin(ttm)
-33.97%
Profit Margin(ttm)
-50.41%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
-41.71%
Return on Assets(ttm)
-16.44%
Income Statement
Revenue(ttm)
900.66M
Revenue Per Share(ttm)
11.68
Gross Profit(ttm)
830.43M
EBITDA(ttm)3
4.37M
Net Income Available to Common(ttm)
-453.20M
Diluted EPS(ttm)
-5.94
Share Statistics
Beta (5Y Monthly)
0.63
52-Week Change
84.21%
S&P 500 52-Week Change
24.74%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
77.13M
Dividend Yield
0.00%
Float4
72.88M
% Held by Insiders
5.50%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
1.01B
Total Cash Per Share(mrq)
13.14
Total Debt(mrq)
2.39B
Total Debt/Equity(mrq)
-226.24%
Current Ratio(mrq)
2.10%
Quick Ratio(mrq)
2.04%
Book Value Per Share(mrq)
-13.70
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.01
Free Cash Flow(ytd)
-52.36M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement